key: cord-0712290-51vw6vjf authors: Karacan, I.; Kizilboga Akgun, T.; Agaoglu, N. B.; Zolfagharian, P.; Aydin, M.; Alkurt, G.; Yildiz, J.; Kose, B.; Can, N. D.; Ozel, A. S.; Altunal, N.; Irvem, A.; Kendir Demirkol, Y.; Akgun Dogan, O.; Doganay, L.; Dinler Doganay, G. title: Genomic Diversity of the SARS-CoV-2 in Turkey and the Impact of Virus Genome Mutations on Clinical Outcomes date: 2020-12-30 journal: nan DOI: 10.1101/2020.12.25.20248851 sha: b46240cd1587b4b092b45cf8e4c62fac6ee8dcb0 doc_id: 712290 cord_uid: 51vw6vjf COVID-19 is a viral respiratory disease caused by SARS-CoV-2 infection. Global efforts of genomic surveillance of the virus give chance to track the spread of the pandemic. Global emergence of some viral mutations called attention and various studies have been suggested about increased infectivity of the virus. Herein, we sequenced viral genomes isolated from 184 patients in Istanbul and analyzed clinical metadata for the investigation of any viral mutation which affects the disease course of the host. We did not detect any viral mutations affecting the disease outcome in our cohort. Besides, we observed intra-host mutations in 76% of the isolates. Insertion/deletion and stop-gain mutations are also significantly less common among intra-host variants compared to consensus viral genome mutations. Longitudinal genomic surveillance is essential for timely detection of any lineages that might affect clinical outcome, the performance of diagnostic assays, or even the immunological escape of the virus. . Conversely, GGG to AAC trinucleotide change at positions 28881-28883 located in the N 165 gene has been detected more frequently in males (48%) compared to females (30.9%) with a 166 p-value of 0.0236. A complete list of tested variants and clinical parameters was given in 167 Table 3. 168 169 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 30, 2020. ; Possibly detrimental intra-host mutations are under negative selection: We generated consensus sequences of each isolate considering the major alleles (>50% of all reads) for genomic positions. Variant calling using NGS data revealed that 140 isolates (76%) have 172 polymorphic sites in which minor allele frequencies (MAF) range between 10-90%. The rest 173 of the samples have mutations only whose allelic frequency was over 90%. We further 174 focused on those polymorphic sites for the presence of any association to clinical parameters. Further, we inspected those intra-host mutations for their occurrence events among isolates. Insertion and deletion mutations together with stop-gain mutations were more frequent in 181 intra-host mutation events with statistical significance whereas non-coding variants were seen 182 less in intra-host mutation events (Table 4 ). The overall frequencies of synonymous and non-183 synonymous mutation events were found not to be statistically significant between intra-host 184 and consensus mutations. We also compared intra-host mutation counts to the clinical 185 manifestations of the patients and no significant difference was detected. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 30, 2020. ; isolates in Istanbul which was the epicenter of the pandemic in Turkey, using a high 204 throughput sequencing method. We evaluated viral genomic changes for any association with 205 the clinical outcomes of the patients. A recent study pointed out that the majority of the analyzed samples in the Similarly, the stop-gain variation rate in inter-host variations was 0.12% whereas its 268 frequency in inter-host variations was ten times more: 1.2%. This result may be due to The authors declare no competing interests. Table 1 : Demographic and clinical characteristics of 184 COVID-19 patients. Age (years, mean ± SD) 49.7± 19.5 Male gender (n, %) 100 (54.3 %) Hypertension 39 (21.5 %) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Leukocyte count (x10 -9 , normal range: 4,000-10,000) 5928,76 ± 2344,74 Lymphocyte count (x10 -9 , normal range: 700 -4,000) 1733,70 ± 775,68 C-reactive protein (mg/dL, normal range: 0 -0.5) 3,91 ± 5,61 Lactate dehydrogenase (U/L, normal range: 125 -220) 341,28 ± 146,45 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) preprint The copyright holder for this this version posted December 30, 2020. ; https://doi.org/10.1101/2020.12.25.20248851 doi: medRxiv preprint RaTG13 Coronavirus Genomes Are Strongly Biased Towards C>U Transitions Their Hosts Sampling bias and 404 incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable Discovery of an RNA virus 3'->5' exoribonuclease that is critically 409 involved in coronavirus RNA synthesis Intra-host site-specific polymorphisms of SARS-CoV-2 is consistent across multiple 413 samples and methodologies. medRxiv Rampant C-->U Hypermutation in the Genomes of SARS-CoV-2 and 416 Other Coronaviruses: Causes and Consequences for Their Short-and Long-Term 417